A Durability Index for Atopic Dermatitis: Indirect Comparison of Lebrikizumab, Dupilumab, and Tralokinumab in Maintaining Efficacy Under Variable Treatment Adherence. - Silverberg, Jonathan I.; Irvine, Alan D.; Foley, Peter; Del Rosso, James; Puig, Luis; Stein Gold, Linda; Kamata, Masahiro; Wollenberg, Andreas; Hong, H. Chih-ho; Chu, Chia-Yu; Binamer, Yousef; Dossenbach, Martin; et al. (Dermatology & Therapy, 2026)